Drug Sellers Move To Finalize $250M TriCor Settlement
A group of drug vendors has moved to finalize a $250 million class action settlement with Abbott Laboratories, which would put to rest a long-running antitrust suit accusing the drug company...To view the full article, register now.
Already a subscriber? Click here to view full article